Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This month symbols : Jnj crawled time : 15:00 save search
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published: 2024-04-24 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: 1.21%
business
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.4%
H: 3.01%
C: 2.94%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
first treatment for
$4.9B Vertex-Alpine Deal Highlights Continued 2024 M&A Upswing
Published: 2024-04-11 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
deal
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
Published: 2024-04-11 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
RLYB | News | $1.59 -8.62% -9.43% 280K
|
|
| O: 104.91%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: 0.0%
H: 2.97%
C: 2.97%
TXMD | News | $1.88 -0.27% 15K
|
Health Technology
|
| O: -0.47%
H: 0.48%
C: -0.95%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: 2.01%
H: 1.35%
C: -0.18%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 8.53%
H: 25.0%
C: 12.86%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.39%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: 0.55%
H: 0.29%
C: -1.41%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.0%
H: 0.96%
C: -1.92%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: 0.49%
H: 1.77%
C: 1.59%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: 0.43%
H: 1.76%
C: 1.55%
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: -1.62%
H: 4.43%
C: 3.67%
biopharma novartis
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.09%
H: 0.16%
C: -0.7%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
for
Basilea Wins FDA Approval for Antibiotic Ending 15-Year Regulatory Quest
Published: 2024-04-04 (Crawled : 15:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
fda approval
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.